Loading…

Liquid chromatography–mass spectrometry method for determination of tetramethylpyrazine and its metabolite in dog plasma

A liquid chromatography–mass spectrometry method is described for the determination of tetramethylpyrazine (TMP) and its active metabolite, 2-hydroxymethyl-3,5,6-trimethylpyrazine (HTMP) in dog plasma. This method involves a plasma clean-up step using protein precipitation procedure followed by LC s...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2004-12, Vol.813 (1), p.263-268
Main Authors: Wang, Peng, Jin, Xin, Qi, Meiling, Fang, Lin
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A liquid chromatography–mass spectrometry method is described for the determination of tetramethylpyrazine (TMP) and its active metabolite, 2-hydroxymethyl-3,5,6-trimethylpyrazine (HTMP) in dog plasma. This method involves a plasma clean-up step using protein precipitation procedure followed by LC separation and positive electrospray ionization mass spectrometry detection (ESI-MS). Chromatographic separation of the analytes was achieved on a C18 column using a mobile phase of methanol, water and acetic acid (50:50:0.6, v/v/v) at a flow rate of 1.0 ml/min. Selected ion monitoring (SIM) mode was used for analyte quantitation at m/ z 137.2 for TMP, m/ z 153.2 for HTMP and m/ z 195.2 for caffeine. The linearity was obtained over the concentration ranges of 20–6000 ng/ml for TMP and 20–4000 ng/ml for HTMP and the lower limit of quantitation was 20 ng/ml for both analytes. For each level of QC samples, both inter- and intra-day precisions (R.S.D.) were ≤7.4% for TMP and ≤6.0% for HTMP, and accuracy (R.E.) was ±6.0% for TMP and ≤3.5% for HTMP. The proposed LC–MS method was successfully applied to the pharmacokinetic studies of a TMP formulation preparation after oral administration to beagle dogs.
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2004.09.048